{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:42:13Z","timestamp":1793472133695,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.contraception.2017.03.004","type":"journal-article","created":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T04:45:49Z","timestamp":1489121149000},"page":"571-577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["The effect of carbamazepine on etonogestrel concentrations in contraceptive implant users"],"prefix":"10.1016","volume":"95","author":[{"given":"Aaron","family":"Lazorwitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryke","family":"Swartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Guiahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2017.03.004_bb0005","series-title":"Contraceptive technology","author":"Hatcher","year":"2011"},{"issue":"Suppl. 2","key":"10.1016\/j.contraception.2017.03.004_bb0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/14730782.2000.12288981","article-title":"The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant","volume":"5","author":"Bennink","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2017.03.004_bb0015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1345\/aph.10149","article-title":"Implanon: a critical review","volume":"35","author":"Le","year":"2001","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.contraception.2017.03.004_bb0020","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/QAI.0000000000000189","article-title":"Effect of antiretroviral therapy including lopinarvir\/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women","volume":"66","author":"Vieira","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.contraception.2017.03.004_bb0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2010.06.013","article-title":"The use of hormonal contraception among women taking anticonvulsant therapy","volume":"83","author":"Gaffield","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2017.03.004_bb0030","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1046\/j.1528-1157.2003.55602.x","article-title":"Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects","volume":"44","author":"Doose","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.contraception.2017.03.004_bb0035","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1528-1167.2010.02917.x","article-title":"Carbamazepine coadministration with an oral contraceptive: effects on steroid pharmacokinetics, ovulation, and bleeding","volume":"52","author":"Davis","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.contraception.2017.03.004_bb0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.seizure.2013.09.007","article-title":"Trends in the first antiepileptic drug prescribed for epilepsy between 2000 and 2010","volume":"23","author":"Pickrell","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.contraception.2017.03.004_bb0045","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.yebeh.2009.04.026","article-title":"Antiepileptic drug use in women of childbearing age","volume":"15","author":"Meador","year":"2009","journal-title":"Epilepsy Behav"},{"issue":"Suppl. 7","key":"10.1016\/j.contraception.2017.03.004_bb0050","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1528-1167.2012.03712.x","article-title":"Why are antiepileptic drugs used for nonepileptic conditions?","volume":"53","author":"Bialer","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.contraception.2017.03.004_bb0055","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0010-7824(98)00110-3","article-title":"Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon","volume":"58","author":"Wenzl","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2017.03.004_bb0060","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/epi.12564","article-title":"Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions","volume":"55","author":"Amstutz","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.contraception.2017.03.004_bb0065","first-page":"133","article-title":"Profiles of drug substance, excipients, and related methodology","volume":"41","author":"Alrashood","year":"2016"},{"key":"10.1016\/j.contraception.2017.03.004_bb0070","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/AOG.0000000000000690","article-title":"Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the U.S. Food and Drug Administration-approved duration","volume":"125","author":"McNicholas","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2017.03.004_bb0075","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/AOG.0b013e318259565a","article-title":"Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women","volume":"120","author":"Xu","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.contraception.2017.03.004_bb0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.contraception.2015.11.005","article-title":"Relationship between etonogestrel level and BMI in women using the contraceptive implant for more than 1 year","volume":"93","author":"Morell","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2017.03.004_bb0090","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/FTD.0b013e31829a10fa","article-title":"A UPLC-MS\/MS method for therapeutic drug monitoring of etonogestrel","volume":"35","author":"Thomas","year":"2013","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.contraception.2017.03.004_bb0095","doi-asserted-by":"crossref","first-page":"85S","DOI":"10.1016\/S0010-7824(98)00120-6","article-title":"Pharmacokinetics of Implanon. An integrated analysis","volume":"58","author":"Huber","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2017.03.004_bb0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1752-1947-8-43","article-title":"Decreased efficacy of an etonogestrel implant in a woman on antiepileptic medications: a case report","volume":"8","author":"Lange","year":"2014","journal-title":"J Med Case Reports"},{"key":"10.1016\/j.contraception.2017.03.004_bb0105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00404-005-0064-4","article-title":"Failure of Implanon contraception in a patient taking carbamazepin for epilepsia","volume":"273","author":"Schindlbeck","year":"2006","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.contraception.2017.03.004_bb0110","author":"U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research"},{"key":"10.1016\/j.contraception.2017.03.004_bb0120","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1258\/ijsa.2009.009469","article-title":"Implanon\u00ae failure in an HIV-positive woman on antiretroviral therapy resulting in two ectopic pregnancies","volume":"22","author":"McCarty","year":"2011","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.contraception.2017.03.004_bb0125","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.contraception.2011.09.005","article-title":"Contraceptive failure of etonogestrel implant in patients treated with antiretrovirals including efavirenz","volume":"85","author":"Leticee","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2017.03.004_bb0130","doi-asserted-by":"crossref","first-page":"39.e1","DOI":"10.1016\/j.ajog.2012.04.022","article-title":"Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women","volume":"207","author":"Westhoff","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2017.03.004_bb0135","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00003088-200039030-00005","article-title":"Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring","volume":"39","author":"Timmer","year":"2000","journal-title":"Clin Pharmacokinet"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782417300719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782417300719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T17:05:57Z","timestamp":1769879157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782417300719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0010782417300719"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2017.03.004","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of carbamazepine on etonogestrel concentrations in contraceptive implant users","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2017.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}